Cerebrospinal fluid biomarkers in patients with varicella-zoster virus CNS infections

Journal of Neurology

Volumn 260, Issue 7, 2013, Pages 1813-1821

  Grahn, Anna ^a   Hagberg, Lars ^a   Nilsson, Staffan ^b   Blennow, Kaj ^a   Zetterberg, Henrik ^a   Studahl, Marie ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

Central nervous system (CNS); Encephalitis; GFAp; NFL protein; Varicella zoster virus (VZV)

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; NEUROFILAMENT PROTEIN; PROTEIN S100B; VIRUS DNA;

ADULT; AGED; APRAXIA; ARTICLE; ASTROCYTOSIS; BALANCE DISORDER; BRAIN DAMAGE; BRAIN DYSFUNCTION; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID; CLINICAL FEATURE; CONSCIOUSNESS DISORDER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DISORIENTATION; DYSPHAGIA; DYSPHASIA; EEG ABNORMALITY; FACIAL NERVE PARALYSIS; FEMALE; FEVER; HEADACHE; HERPES ZOSTER ENCEPHALITIS; HERPES ZOSTER OTICUS; HUMAN; LEG PAIN; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MYELITIS; NAUSEA; NEUROLOGIC DISEASE; NONHUMAN; PERIPHERAL NEUROPATHY; PERSONALITY DISORDER; PLEOCYTOSIS; POLYNEUROPATHY; PRIORITY JOURNAL; PROTEIN ANALYSIS; RADICULITIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEIZURE; VARICELLA ZOSTER VIRUS; VERTIGO; VIRUS LOAD;

ADULT; BIOLOGICAL MARKERS; BRAIN; ENCEPHALITIS, VARICELLA ZOSTER; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HERPESVIRUS 3, HUMAN; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROFILAMENT PROTEINS; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT;

EID: 84880320014     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-013-6883-5     Document Type: Article

References (38)

1. De Broucker T, Mailles A, Chabrier S, Morand P, Stahl JP, Steering Committee, Investigators Group (2012) Acute varicella zoster encephalitis without evidence of primary vasculopathy in a case-series of 20 patients. Clini Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 18(8):808-819. doi: 10.1111/j.1469-0691.2011.03705.x
2. Gilden D (2004) Varicella zoster virus and central nervous system syndromes. Herpes J IHMF 11(Suppl 2):89A-94A
3. Puchhammer-Stockl E, Popow-Kraupp T, Heinz FX, Mandl CW, Kunz C (1991) Detection of varicella-zoster virus DNA by polymerase chain reaction in the cerebrospinal fluid of patients suffering from neurological complications associated with chicken pox or herpes zoster. J Clin Microbiol 29(7):1513-1516
4. Aberle SW, Aberle JH, Steininger C, Puchhammer-Stockl E (2005) Quantitative real time PCR detection of Varicella-zoster virus DNA in cerebrospinal fluid in patients with neurological disease. Med Microbiol Immunol 194(1-2):7-12
5. Persson A, Bergstrom T, Lindh M, Namvar L, Studahl M (2009) Varicella-zoster virus CNS disease - viral load, clinical manifestations and sequels. J Clin Virol Off Publ Pan-Am Soc Clin Virol 46(3):249-253. doi: 10.1016/j.jcv.2009.07.014
6. Aurell A, Rosengren LE, Karlsson B, Olsson JE, Zbornikova V, Haglid KG (1991) Determination of S-100 and glial fibrillary acidic protein concentrations in cerebrospinal fluid after brain infarction. Stroke J Cereb Circ 22(10):1254-1258
7. Rosengren LE, Karlsson JE, Karlsson JO, Persson LI, Wikkelso C (1996) Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF. J Neurochem 67(5):2013-2018
8. Studahl M, Rosengren L, Gunther G, Hagberg L (2000) Difference in pathogenesis between herpes simplex virus type 1 encephalitis and tick-borne encephalitis demonstrated by means of cerebrospinal fluid markers of glial and neuronal destruction. J Neurol 247(8):636-642
9. Petzold A, Groves M, Leis AA, Scaravilli F, Stokic DS (2010) Neuronal and glial cerebrospinal fluid protein biomarkers are elevated after West Nile virus infection. Muscle Nerve 41(1):42-49. doi: 10.1002/mus.21448
10. Lins H, Wallesch CW, Wunderlich MT (2005) Sequential analyses of neurobiochemical markers of cerebral damage in cerebrospinal fluid and serum in CNS infections. Acta Neurol Scand 112(5):303-308. doi: 10.1111/j.1600-0404.2005. 00484.x
11. Teunissen CE, Iacobaeus E, Khademi M, Brundin L, Norgren N, Koel-Simmelink MJ, Schepens M, Bouwman F, Twaalfhoven HA, Blom HJ, Jakobs C, Dijkstra CD (2009) Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis. Neurology 72(15):1322-1329. doi: 10.1212/WNL. 0b013e3181a0fe3f
12. Nylen K, Karlsson JE, Blomstrand C, Tarkowski A, Trysberg E, Rosengren LE (2002) Cerebrospinal fluid neurofilament and glial fibrillary acidic protein in patients with cerebral vasculitis. J Neurosci Res 67(6):844-851
13. Kaneda K, Fujita M, Yamashita S, Kaneko T, Kawamura Y, Izumi T, Tsuruta R, Kasaoka S, Maekawa T (2010) Prognostic value of biochemical markers of brain damage and oxidative stress in post-surgical aneurysmal subarachnoid hemorrhage patients. Brain Res Bull 81(1):173-177. doi: 10.1016/j.brainresbull.2009.10.020
14. Sindic CJ, Chalon MP, Cambiaso CL, Laterre EC, Masson PL (1982) Assessment of damage to the central nervous system by determination of S-100 protein in the cerebrospinal fluid. J Neurol Neurosurg Psychiatry 45(12):1130-1135
15. Dotevall L, Hagberg L, Karlsson JE, Rosengren LE (1999) Astroglial and neuronal proteins in cerebrospinal fluid as markers of CNS involvement in Lyme neuroborreliosis. Eur J Neurol Off J Eur Fed Neurol Soc 6(2):169-178
16. Granerod J, Ambrose HE, Davies NW, Clewley JP, Walsh AL, Morgan D, Cunningham R, Zuckerman M, Mutton KJ, Solomon T, Ward KN, Lunn MP, Irani SR, Vincent A, Brown DW, Crowcroft NS, UKHPAAoES Group (2010) Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 10(12):835-844. doi: 10.1016/S1473-3099(10)70222-X
17. Mailles A, De Broucker T, Costanzo P, Martinez-Almoyna L, Vaillant V, Stahl JP, Steering C, Investigators G (2012) Long-term outcome of patients presenting with acute infectious encephalitis of various causes in France. Clin Infect Dis Off Publ Infect Dis Soc Am 54(10):1455-1464. doi: 10.1093/cid/cis226
18. Mailles A, Stahl JP, Steering C, Investigators G (2009) Infectious encephalitis in France in 2007: a national prospective study. Clin Infect Dis Off Publ Infect Dis Soc Am 49(12):1838-1847. doi: 10.1086/648419
19. Jennett B, Bond M (1975) Assessment of outcome after severe brain damage. Lancet 1(7905):480-484
20. Blennow K, Fredman P, Wallin A, Gottfries CG, Karlsson I, Langstrom G, Skoog I, Svennerholm L, Wikkelso C (1993) Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age. Eur Neurol 33(2):129-133
21. Rosengren LE, Wikkelso C, Hagberg L (1994) A sensitive ELISA for glial fibrillary acidic protein: application in CSF of adults. J Neurosci Methods 51(2):197-204
22. Esiri MM (1982) Herpes simplex encephalitis. An immunohistological study of the distribution of viral antigen within the brain. J Neurol Sci 54(2):209-226
23. Sawlani V, Gupta RK, Singh MK, Kohli A (1997) MRI demonstration of Wallerian degeneration in various intracranial lesions and its clinical implications. J Neurol Sci 146(2):103-108
24. Gilden D, Cohrs RJ, Mahalingam R, Nagel MA (2009) Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet neurology 8(8):731-740. doi: 10.1016/S1474-4422(09)70134-6
25. Gilden DH (2002) Varicella zoster virus vasculopathy and disseminated encephalomyelitis. J Neurol Sci 195(2):99-101
26. Miyazaki Y, Riku Y, Goto Y, Mano K, Yoshida M, Hashizume Y (2008) VZV vasculopathy associated with myelo-radiculoganglio-meningo-encephalitis: an autopsy case of an immunocompetent 66-year-old male. J Neurol Sci 275(1-2):42-45. doi: 10.1016/j.jns.2008.07.019
27. Gilden DH, Kleinschmidt-DeMasters BK, Wellish M, Hedley-Whyte ET, Rentier B, Mahalingam R (1996) Varicella zoster virus, a cause of waxing and waning vasculitis: the new England journal of medicine case 5-1995 revisited. Neurology 47(6):1441-1446
28. Melanson M, Chalk C, Georgevich L, Fett K, Lapierre Y, Duong H, Richardson J, Marineau C, Rouleau GA (1996) Varicella-zoster virus DNA in CSF and arteries in delayed contralateral hemiplegia: evidence for viral invasion of cerebral arteries. Neurology 47(2):569-570
29. Berger TM, Caduff JH, Gebbers JO (2000) Fatal varicella-zoster virus antigen-positive giant cell arteritis of the central nervous system. Pediatr Infect Dis J 19(7):653-656
30. Doyle PW, Gibson G, Dolman CL (1983) Herpes zoster ophthalmicus with contralateral hemiplegia: identification of cause. Ann Neurol 14(1):84-85. doi: 10.1002/ana.410140115
31. Eidelberg D, Sotrel A, Horoupian DS, Neumann PE, Pumarola-Sune T, Price RW (1986) Thrombotic cerebral vasculopathy associated with herpes zoster. Ann Neurol 19(1):7-14. doi: 10.1002/ana.410190103
32. Fukumoto S, Kinjo M, Hokamura K, Tanaka K (1986) Subarachnoid hemorrhage and granulomatous angiitis of the basilar artery: demonstration of the varicella-zoster-virus in the basilar artery lesions. Stroke J Cereb Circ 17(5):1024-1028
33. Takashima S, Becker LE (1979) Neuropathology of fatal varicella. Arch Pathol Lab Med 103(5):209-213
34. Nagel MA, Cohrs RJ, Mahalingam R, Wellish MC, Forghani B, Schiller A, Safdieh JE, Kamenkovich E, Ostrow LW, Levy M, Greenberg B, Russman AN, Katzan I, Gardner CJ, Hausler M, Nau R, Saraya T, Wada H, Goto H, de Martino M, Ueno M, Brown WD, Terborg C, Gilden DH (2008) The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features. Neurology 70(11):853-860
35. Sjogren M, Blomberg M, Jonsson M, Wahlund LO, Edman A, Lind K, Rosengren L, Blennow K, Wallin A (2001) Neurofilament protein in cerebrospinal fluid: a marker of white matter changes. J Neurosci Res 66(3):510-516
36. Ming JE, Stiehm ER, Graham JM Jr (1999) Syndromes associated with immunodeficiency. Adv Pediatr 46:271-351
37. Devinsky O, Cho ES, Petito CK, Price RW (1991) Herpes zoster myelitis. Brain J Neurol 114(Pt 3):1181-1196
38. Schloss L, Falk KI, Skoog E, Brytting M, Linde A, Aurelius E (2009) Monitoring of herpes simplex virus DNA types 1 and 2 viral load in cerebrospinal fluid by real-time PCR in patients with herpes simplex encephalitis. J Med Virol 81(8):1432-1437. doi: 10.1002/jmv.21563